It relates to an Association of chemical agents, with intended pharmacological action to prevent the risk of infarction and brain hemorrhage caused by the development of the atherosclerotic process and of the homocysteinemia resulting from ageing.
It is of the utmost importance to prevent the increase of endogenous homocysteine.
High levels of homocysteine in blood, caused by genetical error and further biologic circumstances impart damaging consequences upon the human organism (occlusion of blood vessels, ocular modifications, osteoporosis and nervous system).
它涉及一个
化学制剂协会,其药理作用是防止因动脉粥样硬化过程和老化引起的同型半胱
氨酸血症的发展而导致脑梗塞和脑出血的风险。
最重要的是防止内源性同型半胱
氨酸的增加。
由于
基因错误和其他
生物因素造成的血液中同型半胱
氨酸含量过高,会对人体造成损害(血管闭塞、眼部病变、骨质疏松症和神经系统)。